The Valley Desk

Clinical trial reportEBioMedicinePublished

The sodium-glutamate antagonist riluzole improves outcome after acute spinal cord injury: results from the RISCIS randomised controlled trial analysed using a global statistical analytic technique

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Penn Medicine, Pennsylvania Hospital, Thomas Jefferson University. Affiliation source

Publication record

Type
Clinical trial report
Venue
EBioMedicine
Published
Subject terms
Humans; Spinal Cord Injuries; Riluzole; Excitatory Amino Acid Antagonists; Neuroprotective Agents; Treatment Outcome; Quality of Life; Adult; Aged; Middle Aged; Female; Male
PubMed ID
40712181
PubMed Central ID
PMC12309938
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal